Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

Clinical trial NCT07148947 · RECRUITING

Trial details

NCT number: NCT07148947
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Accelerated Phase Myeloproliferative Neoplasm Blast Phase Myeloproliferative Neoplasm

Start date: 2026-03-02
Primary completion: 2028-12-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.